Thank you for the question.
Absolutely. Cervical cancer is a priority for us as Canadians, and it's a priority for us at CIHR, in terms of innovative research to address rising incidents of cervical cancer. As I mentioned earlier, we are very proud and fortunate to be able to fund Dr. Gina Ogilvie at the Women's Health Research Institute here in British Columbia. Her work has focused for decades on looking at HPV vaccination, uptake of HPV vaccine and moving us from cervical cancer screening towards HPV screening as a strategy for eliminating cervical cancer in Canada.
The Canadian Partnership Against Cancer, or CPAC, which is funded by the Government of Canada and its partners, has developed an action plan to eliminate cervical cancer in Canada. Importantly, this action plan engages with partners across the country. These partners include women and gender-diverse people with lived and living experience of cervical cancer within the action plan's priorities. To reinforce this, these priorities include improving HPV vaccination rates among young girls and young boys, as well as young women; implementing HPV primary screening; and enhancing efforts to follow up abnormal results of testing procedures.
CPAC also hosts the pan-Canadian cervical cancer screening network, which undertakes system performance for reporting on cervical cancer and support for the development of sharing best practices for screening and treatment.
I'll reinforce that this is a priority area for research, programming and practice to transform cervical cancer incidents among, and their impact on, women and gender-diverse people in Canada. Thank you.